DK3867247T3 - Nye forbindelser - Google Patents

Nye forbindelser Download PDF

Info

Publication number
DK3867247T3
DK3867247T3 DK19790048.3T DK19790048T DK3867247T3 DK 3867247 T3 DK3867247 T3 DK 3867247T3 DK 19790048 T DK19790048 T DK 19790048T DK 3867247 T3 DK3867247 T3 DK 3867247T3
Authority
DK
Denmark
Prior art keywords
new connections
connections
new
Prior art date
Application number
DK19790048.3T
Other languages
English (en)
Inventor
Giuseppe Alvaro
Agostino Marasco
Original Assignee
Autifony Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autifony Therapeutics Ltd filed Critical Autifony Therapeutics Ltd
Application granted granted Critical
Publication of DK3867247T3 publication Critical patent/DK3867247T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK19790048.3T 2018-10-16 2019-10-16 Nye forbindelser DK3867247T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18200626 2018-10-16
PCT/GB2019/052937 WO2020079422A1 (en) 2018-10-16 2019-10-16 Novel compounds

Publications (1)

Publication Number Publication Date
DK3867247T3 true DK3867247T3 (da) 2024-09-16

Family

ID=63878368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19790048.3T DK3867247T3 (da) 2018-10-16 2019-10-16 Nye forbindelser

Country Status (20)

Country Link
EP (1) EP3867247B1 (da)
JP (1) JP7465868B2 (da)
KR (1) KR102854594B1 (da)
AR (1) AR116713A1 (da)
AU (1) AU2019360017B9 (da)
BR (1) BR112021006940A2 (da)
DK (1) DK3867247T3 (da)
ES (1) ES2988842T3 (da)
FI (1) FI3867247T3 (da)
HR (1) HRP20241318T1 (da)
HU (1) HUE068686T2 (da)
IL (1) IL282096B2 (da)
LT (1) LT3867247T (da)
MX (1) MX2021004386A (da)
PL (1) PL3867247T3 (da)
PT (1) PT3867247T (da)
SI (1) SI3867247T1 (da)
TW (1) TWI827706B (da)
WO (1) WO2020079422A1 (da)
ZA (1) ZA202101487B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12358901B2 (en) 2018-10-16 2025-07-15 Autifony Therapeutics Limited KV3 modulators
MX2022009702A (es) * 2020-02-06 2022-09-07 Autifony Therapeutics Ltd Moduladores de kv3.
EP4384165B1 (en) * 2021-08-09 2025-07-09 Janssen Pharmaceutica NV Monoacylglycerol lipase modulators for use in autism spectrum disorders
MX2024001899A (es) 2021-08-10 2024-03-01 Autifony Therapeutics Ltd Moduladores del canal de potasio.
EP4630117A1 (en) 2022-12-06 2025-10-15 Autifony Therapeutics Limited Compounds for the treatment of centra nervous system disorders
WO2026093398A1 (en) 2024-10-29 2026-05-07 Autifony Therapeutics Limited Kv3 modulators for use in the treatment or prophylaxis of amyotrophic lateral sclerosis (als)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2509961T3 (pl) 2009-12-11 2016-09-30 Pochodne imidazolidynodionu
ES2560304T3 (es) * 2010-12-06 2016-02-18 Autifony Therapeutics Limited Derivados de hidantoína útiles como inhibidores de Kv3
GB201209986D0 (en) 2012-06-06 2012-07-18 Autifony Therapeutics Ltd Novel compounds
EP2718285B1 (en) 2011-06-07 2016-03-16 Autifony Therapeutics Limited Hydantoin derivatives as kv3 inhibitors
CN103974944B (zh) * 2011-12-06 2016-11-02 奥蒂福尼疗法有限公司 用作kv3抑制剂的乙内酰脲衍生物
EP2852588B8 (en) * 2012-05-22 2018-01-10 Autifony Therapeutics Limited Hydantoin derivatives as kv3 inhibitors
WO2013175215A1 (en) 2012-05-22 2013-11-28 Autifony Therapeutics Limited Triazoles as kv3 inhibitors
WO2013182851A1 (en) * 2012-06-06 2013-12-12 Autifony Therapeutics Limited Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required
GB201521751D0 (en) * 2015-12-10 2016-01-27 Autifony Therapeutics Ltd Novel uses
GB201522179D0 (en) 2015-12-16 2016-01-27 Autifony Therapeutics Ltd Novel compounds
GB201613163D0 (en) 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
EP3555073A1 (en) * 2016-12-16 2019-10-23 Autifony Therapeutics Limited Hydantoin modulators of kv3 channels

Also Published As

Publication number Publication date
IL282096B2 (en) 2024-07-01
BR112021006940A2 (pt) 2021-07-13
EP3867247B1 (en) 2024-07-24
FI3867247T3 (fi) 2024-10-30
TW202035394A (zh) 2020-10-01
AR116713A1 (es) 2021-06-02
AU2019360017B9 (en) 2025-03-27
WO2020079422A1 (en) 2020-04-23
IL282096B1 (en) 2024-03-01
AU2019360017B2 (en) 2025-03-06
KR20210076081A (ko) 2021-06-23
EP3867247A1 (en) 2021-08-25
PL3867247T3 (pl) 2024-12-09
ZA202101487B (en) 2024-05-30
PT3867247T (pt) 2024-09-17
SI3867247T1 (sl) 2024-11-29
AU2019360017A1 (en) 2021-04-01
JP2022505143A (ja) 2022-01-14
HUE068686T2 (hu) 2025-01-28
JP7465868B2 (ja) 2024-04-11
TWI827706B (zh) 2024-01-01
HRP20241318T1 (hr) 2024-12-20
IL282096A (en) 2021-05-31
KR102854594B1 (ko) 2025-09-02
MX2021004386A (es) 2021-06-04
LT3867247T (lt) 2024-11-11
ES2988842T3 (es) 2024-11-21

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
IL280913A (en) Novel methods
EP3890716A4 (en) COMBINATION THERAPIES
DK3810602T3 (da) Forbindelser
IL280912A (en) Novel methods
EP3801265B1 (en) URINARY FLOWMETER
EP3846674C0 (en) VAGINAL SPECULUM
EP3555124C0 (en) TCR NYESO
EP3849534A4 (en) COMBINATION THERAPIES
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
DK3615527T3 (da) Nye azaquinolin-derivater
DK3565806T3 (da) Nye phenylderivater
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
DK3810633T3 (da) Forbindelser
EP3810860C0 (en) COUPLER
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
EP3721129C0 (en) Cryosphere
DK3668879T3 (da) Nye forbindelser
DK3873472T3 (da) Nye pyridaziner
EP3844177A4 (en) COMBINATION THERAPIES
EP3773733C0 (en) METALLO-LIOTHYRONINE